Interactions between Xenobiotics and DME (XEOTIC)
|
Amino Acid(s), Peptide(s) or Protein(s) |
Peptide |
Click to Show/Hide the Full List of Xenobiotics: 8 Xenobiotics
|
Armadillidin glyc-rich |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO02319
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Armadillidin glyc-rich inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii |
[1] |
Bacteriocin L-1077 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO02378
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Bacteriocin L-1077 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 0.76 ug/ml) |
[2] |
Enterocin E-760 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03253
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Enterocin E-760 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 1.6 ug/ml) |
[3] |
Hydramacin Hm-1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03609
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Hydramacin Hm-1 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii |
[4], [5] |
Leptoglycin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03853
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Leptoglycin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 75 microM) |
[6] |
Magainin-2 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03985
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Magainin-2 inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 30 ug/ml) |
[7], [8] |
Pilosulin Myr b I |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO04606
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Pilosulin Myr b I inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 2 microM) |
[9] |
Pilosulin P1(1-20) |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO04426
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Pilosulin P1(1-20) inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii (MIC = 2 microM) |
[10] |
Pharmaceutical Agent(s) |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Curcumin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00683
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Curcumin inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii |
[11] |
Epigallocatechin gallate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00613
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Epigallocatechin gallate inhibits the drug-metabolizing activity of Beta-lactamase (blaB) from Citrobacter freundii |
[11] |
|
|
|
|
|
|